Related Experiment Videos
Apoptosis in hepatocellular carcinoma.
Jannis Kountouras1, Christos Zavos, Dimitrios Chatzopoulos
1Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki Ippokration Hospital, Thessaloniki, Greece. jannis@med.auth.gr
Hepato-Gastroenterology
|March 13, 2003
Summary
Apoptosis, the programmed cell death, is vital for liver health. Its defects contribute to liver cancer (hepatocellular carcinoma) development and recurrence, suggesting apoptosis-inducing therapies may be effective.
Area of Science:
- Hepatology
- Cancer Biology
- Cellular Biology
Background:
- Apoptosis is essential for removing damaged cells and maintaining liver homeostasis.
- Dysregulation of apoptosis, alongside cellular replication and differentiation, promotes liver preneoplastic and tumoral lesion growth.
- Defects in apoptosis are increasingly implicated in human hepatocellular carcinoma (HCC).
Purpose of the Study:
- To review the role of apoptosis in liver oncogenesis.
- To explore the link between apoptosis defects and hepatocellular carcinoma progression and recurrence.
- To discuss apoptosis-targeting therapeutic strategies for HCC management.
Main Methods:
- Review of clinical and molecular medical analyses.
- Examination of transgenic models of hepatocarcinogenesis.
- Analysis of the roles of apoptosis, tumor suppressors, and DNA repair in genetic lesion accumulation.
Main Results:
- Apoptosis defects and altered cell death/proliferation balance are key in hepatocarcinogenesis.
- Evidence points to defective apoptosis in human hepatocellular carcinoma.
- Apoptosis-related factors may serve as prognostic markers for HCC progression and recurrence.
Conclusions:
- Apoptosis plays a critical role in liver cancer development and progression.
- Targeting apoptosis represents a promising therapeutic avenue for hepatocellular carcinoma management.
- Further research into apoptosis mechanisms can improve HCC early assessment and treatment.